Literature DB >> 27751570

Computational assessment of the effects of the catheter type on particle-hemodynamics during liver radioembolization.

Jorge Aramburu1, Raúl Antón2, Alejandro Rivas1, Juan Carlos Ramos1, Bruno Sangro3, José Ignacio Bilbao4.   

Abstract

Radioembolization, which consist of the implantation of radioactive microspheres via intra-arterially placed microcatheter, is a safe and effective treatment for liver cancer. Nevertheless, radioembolization-related complications and side effects may arise, which are an active area of ongoing research. The catheter design has been claimed as an option in reducing these complications. In this paper, the influence of catheter type and location are investigated. The study was undertaken by numerically simulating the particle-hemodynamics in a patient-specific hepatic artery during liver radioembolization. The parameters modified were cancer scenario (30% liver involvement in the right lobe, 'scenario A', and in both lobes, 'scenario B'), catheter type (standard end-hole microcatheter, SMC, and antireflux catheter, ARC), and the location of the tip in the proper hepatic artery (in the straight part, 'inlet', and near the bifurcation, 'bifurcation'). Comparing ARC with SMC, the maximum and average (over segments) absolute difference in the percentage of particles that reached each segment were 19.62% and 9.06% when injecting near the inlet for scenario A; 3.54% and 1.07% injecting near the bifurcation for scenario A; and 18.31% and 11.85% injecting near the inlet for scenario B. It seems, therefore, that the location of the catheter tip in the artery is crucial in terms of particle distribution. Moreover, even though the near-tip blood flow was altered due to the presence of a catheter, the particle distribution matched the flow split if the distance between the injection point and the first bifurcation encountered enabled the alignment of particles with blood flow. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antireflux catheter; Computational fluid–particle dynamics; Hemodynamics; Hepatic artery; Radioembolization

Mesh:

Year:  2016        PMID: 27751570     DOI: 10.1016/j.jbiomech.2016.09.035

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  6 in total

Review 1.  Particle Distribution in Embolotherapy, How Do They Get There? A Critical Review of the Factors Affecting Arterial Distribution of Embolic Particles.

Authors:  Reza Talaie; Pooya Torkian; Omid Amili; Yasmina Aboufirass; Nassir Rostambeigi; Hamed Jalaeian; Jafar Golzarian
Journal:  Ann Biomed Eng       Date:  2022-05-06       Impact factor: 3.934

2.  A Hybrid Particle-Flow CFD Modeling Approach in Truncated Hepatic Arterial Trees for Liver Radioembolization: A Patient-specific Case Study.

Authors:  Tim Bomberna; Saar Vermijs; Maryse Lejoly; Chris Verslype; Lawrence Bonne; Geert Maleux; Charlotte Debbaut
Journal:  Front Bioeng Biotechnol       Date:  2022-05-30

3.  Direct nanodrug delivery for tumor targeting subject to shear-augmented diffusion in blood flow.

Authors:  Zelin Xu; Clement Kleinstreuer
Journal:  Med Biol Eng Comput       Date:  2018-04-26       Impact factor: 2.602

4.  Computational study of a novel catheter for liver radioembolization.

Authors:  Julio Ortega; Raúl Antón; Juan Carlos Ramos; Alejandro Rivas; Gorka S Larraona; Bruno Sangro; José Ignacio Bilbao; Jorge Aramburu
Journal:  Int J Numer Method Biomed Eng       Date:  2022-02-27       Impact factor: 2.648

5.  A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization.

Authors:  Raúl Antón; Javier Antoñana; Jorge Aramburu; Ana Ezponda; Elena Prieto; Asier Andonegui; Julio Ortega; Isabel Vivas; Lidia Sancho; Bruno Sangro; José Ignacio Bilbao; Macarena Rodríguez-Fraile
Journal:  Sci Rep       Date:  2021-02-16       Impact factor: 4.379

Review 6.  Computational Fluid Dynamics Modeling of Liver Radioembolization: A Review.

Authors:  Jorge Aramburu; Raúl Antón; Macarena Rodríguez-Fraile; Bruno Sangro; José Ignacio Bilbao
Journal:  Cardiovasc Intervent Radiol       Date:  2021-09-13       Impact factor: 2.740

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.